May 21, 2024 2:26 pm
Gymnast continues to shine despite Type 1 diabetes

A device known as the “bionic pancreas” has recently been approved by the FDA for use by diabetics. This innovative technology allows users to input the size of their next meal and an AI algorithm calculates and administers the correct amount of insulin to maintain stable blood sugar levels. The impact of this device has been life-changing for a 15-year-old gymnast named Mia Campos, who was diagnosed with type 1 diabetes five years ago during a competition.

Mia struggled with managing her blood sugar levels using a traditional insulin pump, which required constant programming and often had glitches. However, her pediatric endocrinologist recommended the “bionic pancreas” as a solution, and Mia has found it to be a game-changer. The device clips to her jeans and uses AI software to tailor insulin delivery to her glucose levels. Approved for use in individuals six years and older, the device only requires one entry about the size of the next meal.

The “bionic pancreas” has allowed Mia to focus on her studies and gymnastics training, rather than constantly worrying about carbohydrates and insulin levels. Dr. Jane Lynch, Mia’s endocrinologist, emphasizes the importance of diet and exercise in maintaining stable blood sugar levels, in addition to the benefits of this technology. Mia herself is thrilled with the device and believes it will help many people, especially those with busy lifestyles who struggle to manually manage their insulin levels.

Overall, this new technology has provided hope and relief to diabetics like Mia, allowing them to live more confidently and comfortably with their condition.

Leave a Reply